Want to see HK:1858 full AI Analyst Report?
Top Page
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H
(1858)
Select Model
Select Model
Rating:70Outperform
Price Target:
HK$9.00
▼(-41.52% Downside)
Action:Reiterated
Date:09/06/26
The score is supported primarily by strong financial quality—high margins and extremely low leverage—alongside a solid dividend yield. These positives are tempered by clear technical weakness (downtrend with negative momentum) and softer near-term revenue plus inconsistent cash-flow generation.
Positive Factors
Low leverage / strong balance sheet
An exceptionally low-debt, conservatively financed balance sheet provides durable financial flexibility. It lets the company fund R&D, absorb demand shocks, maintain payouts, and pursue opportunistic capex or M&A without relying on external leverage, supporting long-term resilience.
Negative Factors
Revenue volatility and recent decline
Material top-line volatility, including a sharp revenue decline in 2024, undermines confidence in growth durability. Inconsistent revenue complicates capacity planning, weakens long-term sales momentum, and increases execution risk for sustaining investments and expanding market share.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage / strong balance sheet
An exceptionally low-debt, conservatively financed balance sheet provides durable financial flexibility. It lets the company fund R&D, absorb demand shocks, maintain payouts, and pursue opportunistic capex or M&A without relying on external leverage, supporting long-term resilience.
Read all positive factors
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H (1858) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$5.26B
Dividend Yield5.11%
Average Volume (3M)688.15K
Price to Earnings (P/E)18.6
Beta (1Y)1.26
Revenue Growth10.27%
EPS Growth79.65%
CountryHK
Employees1,078
SectorHealthcare
Sector Strength45
IndustryMedical - Devices
Share Statistics
EPS (TTM)0.70
Shares Outstanding95,140,500
10 Day Avg. Volume1,060,475
30 Day Avg. Volume688,155
Financial Highlights & Ratios
PEG Ratio0.16
Price to Book (P/B)1.71
Price to Sales (P/S)4.89
P/FCF Ratio14.53
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.89
Revenue Forecast (FY)HK$1.26B
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H Business Overview & Revenue Model
Company Description
Beijing Chunlizhengda Medical Instruments Co., Ltd. functions as a prominent entity within the orthopedic medical device industry, dedicated to the development, manufacturing, and distribution of surgical implants, instruments, and associated medi...
How the Company Makes Money
The company primarily makes money by selling orthopedic medical devices (including implants and related surgical instruments) to healthcare providers and/or medical device distributors. Revenue is generated from product sales volume and product mi...
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
92
Very Positive
Cash Flow
70
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 968.95M | 1.05B | 805.86M | 1.21B | 1.20B | 1.11B |
| Gross Profit | 622.31M | 653.40M | 516.49M | 875.89M | 913.53M | 854.54M |
| EBITDA | 329.53M | 309.43M | 169.32M | 340.65M | 366.96M | 360.99M |
| Net Income | 276.25M | 272.54M | 124.99M | 277.82M | 307.72M | 322.36M |
Balance Sheet | ||||||
| Total Assets | 3.59B | 3.66B | 3.47B | 3.65B | 3.41B | 3.00B |
| Cash, Cash Equivalents and Short-Term Investments | 2.13B | 2.22B | 1.89B | 2.10B | 1.72B | 1.74B |
| Total Debt | 3.06M | 3.78M | 866.44K | 1.75M | 1.31M | 1.23M |
| Total Liabilities | 461.32M | 591.90M | 644.39M | 770.33M | 690.07M | 530.58M |
| Stockholders Equity | 3.05B | 2.99B | 2.82B | 2.88B | 2.72B | 2.47B |
Cash Flow | ||||||
| Free Cash Flow | 248.96M | 351.97M | -51.07M | 478.47M | 16.10M | -34.62M |
| Operating Cash Flow | 305.75M | 409.57M | -1.90M | 511.71M | 41.01M | 164.79M |
| Investing Cash Flow | 62.83M | -124.01M | 55.84M | -81.56M | -762.61M | -190.35M |
| Financing Cash Flow | -127.29M | -28.75M | -183.14M | -121.33M | -59.04M | 1.07B |
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H Technical Analysis
Negative
15.39
Price Trends
8.81
Negative
9.35
Negative
11.75
Negative
Market Momentum
-0.27
Positive
33.84
Neutral
13.75
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1858, the sentiment is Negative. The current price of 15.39 is above the 20-day moving average (MA) of 8.47, above the 50-day MA of 8.81, and above the 200-day MA of 11.75, indicating a bearish trend. The MACD of -0.27 indicates Positive momentum. The RSI at 33.84 is Neutral, neither overbought nor oversold. The STOCH value of 13.75 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1858.
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$5.45B | 12.34 | 13.24% | 2.40% | 16.15% | 31.89% | |
70 Outperform | HK$5.26B | 18.57 | 9.20% | 5.11% | 10.27% | 79.65% | |
66 Neutral | HK$7.01B | 18.30 | 9.72% | 1.77% | 39.30% | 109.37% | |
59 Neutral | HK$2.78B | 27.46 | 4.08% | ― | 94.80% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
48 Neutral | HK$3.22B | -19.27 | -7.65% | ― | 21.23% | 36.89% | |
45 Neutral | HK$11.65B | 31.24 | 6.07% | 0.06% | -3.62% | ― |
* Healthcare Sector Average
HK:1858
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H
7.88
-7.26
-47.96%
HK:0853
MicroPort Scientific
6.08
-7.85
-56.39%
HK:9996
Peijia Medical Ltd.
4.77
-2.44
-33.84%
HK:2190
Zylox-Tonbridge Medical Technology Co., Ltd. Class H
20.36
-5.13
-20.13%
HK:1789
AK Medical Holdings Ltd.
4.92
-0.67
-11.93%
HK:2235
MicroTech Medical (Hangzhou) Co., Ltd. Class H
6.60
-1.82
-21.62%
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H Corporate Events
Beijing Chunlizhengda Reports Stable Interim Balance Sheet for First Half of 2026
Aug 28, 2026
Beijing Chunlizhengda Medical Instruments has reported its unaudited consolidated interim results for the six months ended 30 June 2026, prepared in accordance with PRC accounting standards and Hong Kong disclosure rules. The announcement shows th...
Beijing Chunlizhengda Declares Interim Cash Dividend for First Half of 2026
Aug 28, 2026
Beijing Chunlizhengda Medical Instruments Co., Ltd. has declared an interim ordinary cash dividend of RMB 1.3 per 10 shares for the six months ended 30 June 2026, underscoring its commitment to returning capital to shareholders. Key dates and paym...
Beijing Chunlizhengda Schedules Board Meeting to Approve 2026 Interim Results
Aug 13, 2026
Beijing Chunlizhengda Medical Instruments Co., Ltd., a Hong Kong-listed Chinese medical device maker specializing in orthopedic instruments, has announced that its board of directors will convene on 28 August 2026. The meeting will review and appr...
Beijing Chunlizhengda reshapes board leadership and committees for sixth session
Jun 26, 2026
Beijing Chunlizhengda Medical Instruments Co., Ltd., a Hong Kong-listed Chinese medical instruments maker, has formalized the composition of its sixth board session to strengthen corporate governance through dedicated audit, remuneration, nominati...
Beijing Chunlizhengda Sets Out Board and Committee Structure
Jun 26, 2026
Beijing Chunlizhengda Medical Instruments has detailed the composition of its board of directors, including executive, non-executive and independent non-executive members, as well as the appointment of a general manager, underscoring a formal gove...
Beijing Chunlizhengda Confirms Valid Poll Results at Extraordinary General Meeting
Jun 25, 2026
Beijing Chunlizhengda Medical Instruments Co., Ltd. held an Extraordinary General Meeting on 25 June 2026 in Beijing, convened by the board and chaired by Chairwoman Shi Wenling, with all directors in attendance either in person or by telephone. T...
Beijing Chunlizhengda Names Veteran R&D Executive as Employee Director
Jun 25, 2026
Beijing Chunlizhengda Medical Instruments Co., Ltd. has appointed executive director and board secretary Xie Feng Bao as the employee director for its sixth board session, following approval at an employee representatives’ meeting on 25 June...
Beijing Chunlizhengda Deploys Idle Funds Into RMB895 Million Bank Wealth Products
Jun 25, 2026
Beijing Chunlizhengda Medical Instruments has allocated significant funds into bank structured deposits and large-denomination certificates of deposit, using both internal resources and temporarily idle A-share proceeds. The company and its subsid...
Beijing Chunlizhengda Calls June 2026 EGM to Reset Board and Pay Structure
Jun 8, 2026
Beijing Chunlizhengda Medical Instruments Co., Ltd. has called an extraordinary general meeting for 25 June 2026 in Beijing to seek shareholder approval for a new remuneration system covering directors and senior management, including specific pay...
Chunlizhengda Wins H Shareholders’ Approval for H-Share Buyback Mandate
Jun 7, 2026
Beijing Chunlizhengda Medical Instruments Co., Ltd. reported the poll results of its adjourned H Shareholders’ Class Meeting held in Beijing on 5 June 2026, which was convened in compliance with PRC laws, Hong Kong listing rules and the comp...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.